Mostrar el registro sencillo del ítem

dc.contributor.authorDíez Ricote, Laura
dc.contributor.authorBueno Cavanillas, Aurora 
dc.date.accessioned2023-01-17T13:12:52Z
dc.date.available2023-01-17T13:12:52Z
dc.date.issued2022-12-16
dc.identifier.citationLaura Díez-Ricote... [et al.]. One-year longitudinal association between changes in dietary choline or betaine intake and cardiometabolic variables in the PREvención con DIeta MEDiterránea-Plus (PREDIMED-Plus) trial, The American Journal of Clinical Nutrition, Volume 116, Issue 6, December 2022, Pages 1565–1579, [https://doi.org/10.1093/ajcn/nqac255]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/79064
dc.description.abstractBackground: Choline and betaine intakes have been related to cardiovascular health. Objectives: We aimed to explore the relation between 1-y changes in dietary intake of choline or betaine and 1-y changes in cardiometabolic and renal function traits within the frame of the PREDIMED (PREvención con DIeta MEDiterránea)-Plus trial. Methods: We used baseline and 1-y follow-up data from 5613 participants (48.2% female and 51.8% male; mean ± SD age: 65.01 ± 4.91 y) to assess cardiometabolic traits, and 3367 participants to assess renal function, of the Spanish PREDIMEDPlus trial. Participants met ≥3 criteria of metabolic syndrome and had overweight or obesity [BMI (in kg/m2) ≥27 and ≤40]. These criteria were similar to those of the PREDIMED parent study. Dietary intakes of choline and betaine were estimated from the FFQ. Results: The greatest 1-y increase in dietary choline or betaine intake (quartile 4) was associated with improved serum glucose concentrations (−3.39 and −2.72 mg/dL for choline and betaine, respectively) and HbA1c levels (−0.10% for quartile 4 of either choline or betaine intake increase). Other significant changes associated with the greatest increase in choline or betaine intake were reduced body weight (−2.93 and −2.78 kg, respectively), BMI (−1.05 and −0.99, respectively), waist circumference (−3.37 and −3.26 cm, respectively), total cholesterol (−4.74 and −4.52 mg/dL, respectively), and LDL cholesterol (−4.30 and −4.16 mg/dL, respectively). Urine creatinine was reduced in quartile 4 of 1-y increase in choline or betaine intake (−5.42 and −5.74 mg/dL, respectively). Conclusions: Increases in dietary choline or betaine intakes were longitudinally related to improvements in cardiometabolic parameters. Markers of renal function were also slightly improved, and they require further investigation. This trial was registered at https://www.isrctn.com/ as ISRCTN89898870. Am J Clin Nutr 2022;116:1565–1579.es_ES
dc.description.sponsorshipMinisterio de Ciencia e Innovacion through Proyectos de I+D+i "Retos Investigacion" RTI2018-095569-B-I00 Ministerio de Ciencia e Innovacion through Programacion Conjunta Internacional PCI2018-093009es_ES
dc.description.sponsorshipEuropean Research Council (ERC) European Commission 20142019 340918es_ES
dc.description.sponsorshipCIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN)es_ES
dc.description.sponsorshipInstituto de Salud Carlos III (ISCIII), through the Fondo de Investigacion para la Salud (FIS) - European Regional Development Fund PI13/00673 PI13/00492 PI13/00272 PI13/01123 PI13/00462 PI13/00233 PI13/02184 PI13/00728 PI13/01090 PI13/01056 PI14/01722 PI14/00636 PI14/00618 PI14/00696 PI14/01206 PI14/01919 PI14/00853 PI14/01374 PI14/00972 PI14/00728 PI14/01471 PI16/00473es_ES
dc.description.sponsorshipA Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigacion para la Salud (FIS) - European Regional Development Fund PI16/00662 PI16/01873 PI16/01094 PI16/00501 PI16/00533 PI16/00381 PI16/00366 PI16/01522 PI16/01120 PI17/00764 PI17/01183 PI17/00855 PI17/01347 PI17/00525 PI17/01827 PI17/00532 PI17/00215 PI17/01441es_ES
dc.description.sponsorshipThe Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigacion para la Salud (FIS) - European Regional Development Fund PI17/00508 PI17/01732 PI17/00926 PI19/00957 PI19/00386 PI19/00309 PI19/01032 PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138 PI20/01532 PI20/00456 PI20/00339 PI20/00557 PI20/00886 PI20/01158es_ES
dc.description.sponsorshipEspecial Action Project "Implementacion y evaluacion de una intervencion intensiva sobre la actividad fisica Cohorte PREDIMED-Plus"es_ES
dc.description.sponsorshipRecercaixa grant 2013ACUP00194es_ES
dc.description.sponsorshipICREA (Catalan Institution for Research and Advanced Studies) under the ICREA Academia program SEMERGEN grantes_ES
dc.description.sponsorshipGovernment of Navarra Department of Health 61/2015es_ES
dc.description.sponsorshipFundacio La Marato de TV3 grant 201630.10es_ES
dc.description.sponsorshipAstraZeneca T2D 2017es_ES
dc.description.sponsorshipJunta de Andalucia PI0458/2013 PS0358/2016 PI0137/2018es_ES
dc.description.sponsorshipCenter for Forestry Research & Experimentation (CIEF)es_ES
dc.description.sponsorshipEuropean Commission PROMETEO/2017/017es_ES
dc.description.sponsorshipBalearic Islands Government 35/2011es_ES
dc.description.sponsorshipSpanish Ministerio de Ciencia e Innovacion y Ministerio de Universidades Spanish State Research Agency Juan de la Cierva Program FJC2018-038168-Ies_ES
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.rightsAtribución-NoComercial 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectCholinees_ES
dc.subjectBetainees_ES
dc.subjectMediterranean dietes_ES
dc.subjectCardiovascular disease riskes_ES
dc.subjectCardiometabolic parameterses_ES
dc.subjectRenal variableses_ES
dc.titleOne-year longitudinal association between changes in dietary choline or betaine intake and cardiometabolic variables in the PREvención con DIeta MEDiterránea-Plus (PREDIMED-Plus) triales_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/340918es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.1093/ajcn/nqac255
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial 4.0 Internacional